drugset / Trial / NCT06441318

A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants

NCT06441318

Phase 1 Completed 128 enrolled Incyte Corporation
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of povorcitinib on the QT/QTc Interval in healthy participants.

Timeline

Start
2024-07-12
Primary completion
2024-09-10
Completion
2024-09-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule
Subject Povorcitinib Small molecule

Indications

No indication recorded.